Ventas/$VTR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Ventas

Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Ticker

$VTR

Primary listing

NYSE

Industry

Health Care REITs

Employees

498

ISIN

US92276F1003

Ventas Metrics

BasicAdvanced
$29B
193.43
$0.33
0.97
$1.83
3.03%

What the Analysts think about Ventas

Analyst ratings (Buy, Hold, Sell) for Ventas stock.

Bulls say / Bears say

Ventas reported a 15.3% year-over-year growth in Same-Store Cash NOI for its senior housing operating portfolio in Q3 2024, driven by a 350 basis point increase in average occupancy. (Ventas Q3 2024 Earnings Release)
The company closed or placed under contract $1.7 billion in senior housing investments year-to-date by Q3 2024, indicating a strong commitment to expanding its portfolio. (Ventas Q3 2024 Earnings Release)
Ventas affirmed its FY2025 FFO guidance of $3.35-$3.46 per share, reflecting confidence in its financial outlook. (Compensation Recovery News)
Ventas has a debt-to-equity ratio of 121.4%, indicating a high level of leverage that could pose financial risks. (Simply Wall St Financial Health Metrics)
The company's interest coverage ratio is 1.3x, suggesting limited ability to cover interest expenses from operating income. (Simply Wall St Financial Health Metrics)
Ventas reported a net loss of $66.5 million in the most recent fiscal year, raising concerns about profitability. (Alpha Spread Income Statement)
Data summarised monthly by Lightyear AI. Last updated on 11 Jun 2025.

Ventas Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Ventas Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $VTR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Jun30
Ventas
Dividend·Ex-dividend
Jul17
Ventas
Dividend·Payment
$0.48Per share
FAQs